To raise awareness of Fabry disease in the differential diagnosis of adult-onset left ventricular hypertrophy, emphasizing its significance in preventing misdiagnosis.
Key Findings:
Fabry disease can present with symptoms overlapping those of coronary artery disease and hypertrophic cardiomyopathy.
Significant diagnostic delays can occur, often exceeding 10 years, underscoring the need for improved awareness and diagnostic pathways.
A diagnostic pathway including clinical signs, imaging, enzymatic assays, and genetic testing is crucial.
Interpretation:
The case illustrates the complexities in diagnosing Fabry disease, particularly when cardiac symptoms dominate, complicating the clinical picture.
Limitations:
The case study is based on a single patient, which may limit generalizability to broader populations.
The reasons for not initiating enzyme replacement therapy were not detailed, which could impact treatment understanding.
Conclusion:
Awareness of Fabry disease's presentation can aid in timely diagnosis and management.
